Sort
8,912 grants matching “sars cov 2”
Core Support for Cancer Center
$334,913Edward Chu · Albert Einstein College Of Medicine · P30 · FY2022 · CA
Computational Design, Bioinformatics &Screening
$334,432University Of Illinois At Chicago · P01 · FY2005 · AI
A Microfluidic System Coupling Amplified Nanofluidic Virion Purification and Mass Spectrometry for Detection of SARS-CoV-2
$334,234Aaron Timperman · University Of Illinois At Urbana-Champaign · R01 · FY2020 · EB
The biochemical mechanism and pharmacological inhibition of phosphatidylinositol phosphate kinases
$334,149Ya Ha · Yale University · R01 · FY2024 · GM
The biochemical mechanism and pharmacological inhibition of phosphatidylinositol phosphate kinases
$334,124Ya Ha · Yale University · R01 · FY2025 · GM
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L
$334,030Mark T Heise · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
System Immunogenetics of SARS-CoV Infection
$334,030Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
Novel Orally Available CBP/Beta-Catenin Antagonists to Treat Idiopathic Pulmonary Fibrosis
$334,008Omar Haffar · 3+2 Pharma, Llc · R43 · FY2022 · HL
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS
$334,006Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Persistence and Evolution of SARS-CoV-2
$333,830Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
SARS-CoV Proteins in Heterologous Viral Infection
$333,807John T. Harty · University Of Iowa · P01 · FY2008 · AI
SARS-CoV Proteins in Heterologous Viral Infection
$333,804John T. Harty · University Of Iowa · P01 · FY2007 · AI
Covid-19 induced worsening of glomerular diseases
$333,696Camille Emilie Adeline Mace · Rush University Medical Center · R01 · FY2024 · DK
Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug
$333,239Weidong Wang · National Institute On Aging · ZIA · FY2021 · AG
Impacts of COVID-19 and racial discrimination on mental, physical, and psychophysiological health in Black pregnant and postpartum persons
$333,200Vasiliki Michopoulos · Emory University · R01 · FY2021 · MH
Transport of Virus-like Nanoparticles through Mucus
$333,135Ashis Mukhopadhyay · Wayne State University · · FY2021 · ENG
SARS-CoV-2 infection of non-human primates
$332,847Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
$332,767Huafeng Wei · University Of Pennsylvania · R01 · FY2021 · AG
Core-001
$332,737William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2020 · AI
Immune Monitoring Core
$332,563Andrew S. Neish · Emory University · U54 · FY2022 · CA
SARS-CoV Proteins in Heterologous Viral Infection
$332,488University Of Iowa · P01 · FY2005 · AI
Development of a COVID Vaccine Model in NHP
$332,304Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development of a COVID Vaccine Model in NHP
$332,304Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Synthetically Accessible Virtual Inventory (SAVI)
$332,143Marc Nicklaus · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Long-term consequences of SARS-CoV-2 infection and COVID-19 disease among American Indians: an ambidirectional cohort study in the Cherokee Nation
$332,051Katrin Gaardbo Kuhn · Cherokee Nation · S06 · FY2025 · GM